CD274 and neoplasm: PRV-induced upregulation of PD-L1 in tumor microenvironments may hamper T-cell-mediated killing of tumor cells, and the expression of iPD-L1 may counteract this inhibition, explaining the enhanced anti-tumor activity of rPRV-iPD-L1.